REFERENCES
1. World Health Organization. Obesity and overweight. 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. [Last accessed on 6 Jan 2026].
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:766-81.
3. Ward ZJ, Bleich SN, Cradock AL, et al. Projected U.S. State-level prevalence of adult obesity and severe obesity. N Engl J Med. 2019;381:2440-50.
4. Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822-32.
5. Clapp B, Ponce J, Corbett J, et al. American Society for Metabolic and Bariatric Surgery 2022 estimate of metabolic and bariatric procedures performed in the United States. Surg Obes Relat Dis. 2024;20:425-31.
6. Monteiro Delgado L, Fabretina de Souza V, Fontel Pompeu B, et al. Long-term outcomes in sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of randomized trials. Obes Surg. 2025;35:3246-57.
7. Courcoulas AP, Christian NJ, Belle SH, et al.; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA. 2013;310:2416-25.
8. Clapp B, Wynn M, Martyn C, Foster C, O’Dell M, Tyroch A. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018;14:741-7.
9. Lessing Y, Pencovich N, Lahat G, Klausner JM, Abu-Abeid S, Meron Eldar S. Laparoscopic sleeve gastrectomy for diabetics - 5-year outcomes. Surg Obes Relat Dis. 2017;13:1658-63.
10. Mechanick JI, Apovian C, Brethauer S, et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists - executive summary. Endocr Pract. 2019;25:1346-59.
11. Aizpuru M, Glasgow AE, Salame M, et al. Bariatric surgery outcomes in patients with bipolar or schizoaffective disorders. Surg Obes Relat Dis. 2023;19:1085-92.
12. Sánchez-Pernaute A, Herrera MAR, Pérez-Aguirre ME, et al. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). One to three-year follow-up. Obes Surg. 2010;20:1720-6.
13. De Luca M, Tie T, Ooi G, et al. Mini gastric bypass-one anastomosis gastric bypass (MGB-OAGB)-IFSO Position Statement. Obes Surg. 2018;28:1188-206.
14. Perrotta G, Bocchinfuso S, Jawhar N, et al. Novel surgical interventions for the treatment of obesity. J Clin Med. 2024;13:5279.
15. Gagner M. Hypoabsorption not malabsorption, hypoabsorptive surgery and not malabsorptive surgery. Obes Surg. 2016;26:2783-4.
16. Poghosyan T, Krivan S, Baratte C. Bile or acid reflux post one-anastomosis gastric bypass: what must we do? Still an unsolved enigma. J Clin Med. 2022;11:3346.
17. Andalib A, Bouchard P, Alamri H, Bougie A, Demyttenaere S, Court O. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S): short-term outcomes from a prospective cohort study. Surg Obes Relat Dis. 2021;17:414-24.
18. Enochs P, Bull J, Surve A, et al. Comparative analysis of the single-anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S) to established bariatric procedures: an assessment of 2-year postoperative data illustrating weight loss, type 2 diabetes, and nutritional status in a single US center. Surg Obes Relat Dis. 2020;16:24-33.
19. Kallies K, Rogers AM; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery updated statement on single-anastomosis duodenal switch. Surg Obes Relat Dis. 2020;16:825-30.
21. Arakkakunnel J, Grover K. One anastomosis gastric bypass and mini gastric bypass. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK608008/. [Last accessed on 6 Jan 2026].
22. Ghiassi S, Nimeri A, Aleassa EM, Grover BT, Eisenberg D, Carter J; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery position statement on one-anastomosis gastric bypass. Surg Obes Relat Dis. 2024;20:319-35.
23. Salminen P, Kow L, Aminian A, et al.; IFSO Experts Panel. IFSO consensus on definitions and clinical practice guidelines for obesity management - an International Delphi study. Obes Surg. 2024;34:30-42.
24. Robert M, Espalieu P, Pelascini E, et al. Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet. 2019;393:1299-309.
25. Lazzati A, Poghosyan T, Touati M, Collet D, Gronnier C. Risk of esophageal and gastric cancer after bariatric surgery. JAMA Surg. 2023;158:264-71.
26. Gallucci P, Marincola G, Pennestrì F, et al. One-anastomosis gastric bypass (OABG) vs. single anastomosis duodeno-ileal bypass (SADI) as revisional procedure following sleeve gastrectomy: results of a multicenter study. Langenbecks Arch Surg. 2024;409:128.
27. Neuberg M, Blanchet MC, Gignoux B, Frering V. Long-term outcomes after one-anastomosis gastric bypass (OAGB) in morbidly obese patients. Obes Surg. 2020;30:1379-84.
28. Carandina S, Soprani A, Zulian V, Cady J. Long-term results of one anastomosis gastric bypass: a single center experience with a minimum follow-up of 10 years. Obes Surg. 2021;31:3468-75.
29. Carbajo MA, Luque-de-León E, Jiménez JM, Ortiz-de-Solórzano J, Pérez-Miranda M, Castro-Alija MJ. Laparoscopic one-anastomosis gastric bypass: technique, results, and long-term follow-up in 1200 patients. Obes Surg. 2017;27:1153-67.
30. Almuhanna M, Soong TC, Lee WJ, Chen JC, Wu CC, Lee YC. Twenty years’ experience of laparoscopic 1-anastomosis gastric bypass: surgical risk and long-term results. Surg Obes Relat Dis. 2021;17:968-75.
31. Tarhini A, Rives-Lange C, Jannot AS, et al. One-anastomosis gastric bypass revision for gastroesophageal reflux disease: long versus short biliopancreatic limb Roux-en-Y gastric bypass. Obes Surg. 2022;32:970-8.
32. Parikh M, Eisenberg D, Johnson J, El-Chaar M; American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery review of the literature on one-anastomosis gastric bypass. Surg Obes Relat Dis. 2018;14:1088-92.
33. Solouki A, Kermansaravi M, Davarpanah Jazi AH, Kabir A, Farsani TM, Pazouki A. One-anastomosis gastric bypass as an alternative procedure of choice in morbidly obese patients. J Res Med Sci. 2018;23:84.
34. Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis. Obes Surg. 2019;29:2721-30.
35. Ganipisetti VM, Naha S. Bariatric surgery malnutrition complications. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK592383/. [Last accessed on 6 Jan 2026].
36. Syn NL, Lee PC, Kovalik JP, et al. Associations of bariatric interventions with micronutrient and endocrine disturbances. JAMA Netw Open. 2020;3:e205123.
37. Wei JH, Lee WJ, Chong K, et al. High incidence of secondary hyperparathyroidism in bariatric patients: comparing different procedures. Obes Surg. 2018;28:798-804.
38. Benalcazar DA, Cascella M. Obesity surgery preoperative assessment and preparation. StatPearls. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK594256/.[Last accessed on 6 Jan 2026].
39. Baksi A, Kamtam DNH, Aggarwal S, Ahuja V, Kashyap L, Shende DR. Should surveillance endoscopy be routine after one anastomosis gastric bypass to detect marginal ulcers: initial outcomes in a tertiary referral centre. Obes Surg. 2020;30:4974-80.
40. Brown WA, Johari Halim Shah Y, Balalis G, et al. IFSO Position Statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30:3135-53.
41. Heidelbaugh JJ. Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications. Ther Adv Drug Saf. 2013;4:125-33.
42. Mostafapour E, Shahsavan M, Shahmiri SS, Jawhar N, Ghanem OM, Kermansaravi M. Prevention of malnutrition after one anastomosis gastric bypass: value of the common channel limb length. BMC Surg. 2024;24:156.
43. Cottam D, Cottam S, Surve A. Single-anastomosis duodenal ileostomy with sleeve gastrectomy “continued innovation of the duodenal switch”. Surg Clin North Am. 2021;101:189-98.
44. Hess DS, Hess DW, Oakley RS. The biliopancreatic diversion with the duodenal switch: results beyond 10 years. Obes Surg. 2005;15:408-16.
46. Salame M, Teixeira AF, Lind R, et al. Marginal ulcer and dumping syndrome in patients after duodenal switch: a multi-centered study. J Clin Med. 2023;12:5600.
47. Tomey D, Hage K, Jawhar N, et al. The rise of the duodenal switch: a narrative review. Ann Laparosc Endosc Surg. 2024;9:37.
48. Yashkov Y, Bordan N, Torres A, Malykhina A, Bekuzarov D. SADI-S 250 vs Roux-en-Y duodenal switch (RY-DS): results of 5-year observational study. Obes Surg. 2021;31:570-9.
49. Surve A, Cottam D, Medlin W, et al. Long-term outcomes of primary single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Surg Obes Relat Dis. 2020;16:1638-46.
50. Hu L, Wang L, Li S, et al. Evaluation study of single-anastomosis duodenal-ileal bypass with sleeve gastrectomy in the treatment of Chinese obese patients based on efficacy and nutrition. Sci Rep. 2024;14:6522.
51. Verhoeff K, Mocanu V, Jogiat U, et al. Patient selection and 30-day outcomes of SADI-S compared to RYGB: a retrospective cohort study of 47,375 patients. Obes Surg. 2022;32:1-8.
52. Palmieri L, Pennestrì F, Raffaelli M. SADI-S, state of the art. Indications and results in 2024: a systematic review of literature. Updates Surg. 2025;77:2037-50.
53. Verhoeff K, Mocanu V, Zalasky A, et al. Evaluation of metabolic outcomes following SADI-S: a systematic review and meta-analysis. Obes Surg. 2022;32:1049-63.
54. Sánchez-Pernaute A, Rubio MÁ, Pérez Aguirre E, Barabash A, Cabrerizo L, Torres A. Single-anastomosis duodenoileal bypass with sleeve gastrectomy: metabolic improvement and weight loss in first 100 patients. Surg Obes Relat Dis. 2013;9:731-5.
55. Shoar S, Poliakin L, Rubenstein R, Saber AA. Single anastomosis duodeno-ileal switch (SADIS): a systematic review of efficacy and safety. Obes Surg. 2018;28:104-13.
56. Topart P, Becouarn G. The single anastomosis duodenal switch modifications: a review of the current literature on outcomes. Surg Obes Relat Dis. 2017;13:1306-12.
57. Ponce de Leon-Ballesteros G, Romero-Velez G, Higa K, et al. Single anastomosis duodeno-ileostomy with sleeve gastrectomy/single anastomosis duodenal switch (SADI-S/SADS) IFSO Position Statement-update 2023. Obes Surg. 2024;34:3639-85.
58. Sánchez-Pernaute A, Herrera MÁR, Ferré NP, et al. Long-term results of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Obes Surg. 2022;32:682-9.
59. Cottam A, Cottam D, Roslin M, et al. A matched cohort analysis of sleeve gastrectomy with and without 300 cm loop duodenal switch with 18-month follow-up. Obes Surg. 2016;26:2363-9.
60. Surve A, Cottam D, Belnap L, Richards C, Medlin W. Long-term (> 6 years) outcomes of duodenal switch (DS) versus single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S): a matched cohort study. Obes Surg. 2021;31:5117-26.
61. Sjöström L, Narbro K, Sjöström CD, et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741-52.
62. Pennestrì F, Sessa L, Prioli F, et al. Single anastomosis duodenal-ileal bypass with sleeve gastrectomy (SADI-S): experience from a high-bariatric volume center. Langenbecks Arch Surg. 2022;407:1851-62.
63. Spinos D, Skarentzos K, Esagian SM, Seymour KA, Economopoulos KP. The effectiveness of single-anastomosis duodenoileal bypass with sleeve gastrectomy/one anastomosis duodenal switch (SADI-S/OADS): an updated systematic review. Obes Surg. 2021;31:1790-800.
64. Gross A, Gentle C, Wehrle CJ, et al. Nonsteroidal anti-inflammatory drug (NSAID) prescribing after gastrojejunostomy: a preventable cause of morbidity. Surgery. 2025;179:108806.
65. Surve A, Cottam D, Sanchez-Pernaute A, et al. The incidence of complications associated with loop duodeno-ileostomy after single-anastomosis duodenal switch procedures among 1328 patients: a multicenter experience. Surg Obes Relat Dis. 2018;14:594-601.
66. Cirera A, Vilallonga R, Ruiz de Gordejuela AG, et al. Complications after single anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) a retrospective review of cases in a high-volume European center. J Am Coll Surg. 2021;233:e1-2.
67. Martinino A, Bhandari M, Abouelazayem M, Abdellatif A, Koshy RM, Mahawar K. Perforated marginal ulcer after gastric bypass for obesity: a systematic review. Surg Obes Relat Dis. 2022;18:1168-75.
68. Portela R, Marrerro K, Vahibe A, et al. Bile reflux after single anastomosis duodenal-ileal bypass with sleeve (SADI-S): a meta-analysis of 2,029 patients. Obes Surg. 2022;32:1516-22.
69. Gebellí JP, Lazzara C, de Gordejuela AGR, et al. Duodenal switch vs. single-anastomosis duodenal switch (SADI-S) for the treatment of grade IV obesity: 5-year outcomes of a multicenter prospective cohort comparative study. Obes Surg. 2022;32:3839-46.
70. Bashah M, Aleter A, Baazaoui J, El-Menyar A, Torres A, Salama A. Single anastomosis duodeno-ileostomy (SADI-S) versus one anastomosis gastric bypass (OAGB-MGB) as revisional procedures for patients with weight recidivism after sleeve gastrectomy: a comparative analysis of efficacy and outcomes. Obes Surg. 2020;30:4715-23.
71. Esparham A, Roohi S, Ahmadyar S, et al. The efficacy and safety of laparoscopic single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S) in mid- and long-term follow-up: a systematic review. Obes Surg. 2023;33:4070-9.
72. Thorell A, MacCormick AD, Awad S, et al. Guidelines for perioperative care in bariatric surgery: Enhanced Recovery after Surgery (ERAS) Society recommendations. World J Surg. 2016;40:2065-83.
73. Gan TJ, Diemunsch P, Habib AS, et al.; Society for Ambulatory Anesthesia. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2014;118:85-113.
74. Harker MJR, Heusschen L, Monpellier VM, et al. Five year outcomes of primary and secondary single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S). Obes Surg. 2025;35:2160-73.
75. Haddad A, Kow L, Herrera MF, et al. Innovative bariatric procedures and ethics in bariatric surgery: the IFSO Position Statement. Obes Surg. 2022;32:3217-30.
76. Santoro S, Malzoni CE, Velhote MC, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16:1371-9.
77. Zhao S, Li R, Zhou J, Sun Q, Wang W, Wang D. Sleeve gastrectomy with transit bipartition: a review of the literature. Expert Rev Gastroenterol Hepatol. 2023;17:451-9.
78. Taskin HE, Al M. Longitudinal outcomes through 4 years after sleeve gastrectomy with transit bipartition. Bariatr Surg Pract Patient Care. 2022;17:225-36.
79. Karaca FC. Effects of sleeve gastrectomy with transit bipartition on glycemic variables, lipid profile, liver enzymes, and nutritional status in type 2 diabetes mellitus patients. Obes Surg. 2020;30:1437-45.
80. Al M, Taskin HE. Sleeve gastrectomy with transit bipartition in a series of 883 patients with mild obesity: early effectiveness and safety outcomes. Surg Endosc. 2022;36:2631-42.
81. Azevedo FR, Santoro S, Correa-Giannella ML, et al. A prospective randomized controlled trial of the metabolic effects of sleeve gastrectomy with transit bipartition. Obes Surg. 2018;28:3012-9.
82. Liu P, Widjaja J, Dolo PR, et al. Comparing the anti-diabetic effect of sleeve gastrectomy with transit bipartition against sleeve gastrectomy and Roux-en-Y gastric bypass using a diabetic rodent model. Obes Surg. 2021;31:2203-10.
83. Baratte C, Willemetz A, Ribeiro-Parenti L, et al. Analysis of the efficacy and the long-term metabolic and nutritional status of sleeve gastrectomy with transit bipartition compared to Roux-en-Y gastric bypass in obese rats. Obes Surg. 2023;33:1121-32.
84. Santoro S, Castro LC, Velhote MC, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012;256:104-10.
85. Calisir A, Ece I, Yilmaz H, et al. The mid-term effects of transit bipartition with sleeve gastrectomy on glycemic control, weight loss, and nutritional status in patients with type 2 diabetes mellitus: a retrospective analysis of a 3-year follow-up. Obes Surg. 2021;31:4724-33.
86. Topart P, Becouarn G, Finel JB. Is transit bipartition a better alternative to biliopancreatic diversion with duodenal switch for superobesity? Comparison of the early results of both procedures. Surg Obes Relat Dis. 2020;16:497-502.
87. Topart P, Becouarn G, Finel JB. Comparison of 2-year results of Roux-en-Y gastric bypass and transit bipartition with sleeve gastrectomy for superobesity. Obes Surg. 2020;30:3402-7.
88. Clyde DR, Adib R, Baig S, et al. An international Delphi consensus on patient preparation for metabolic and bariatric surgery. Clin Obes. 2025;15:e12722.
89. Reiser M, Christogianni V, Nehls F, Dukovska R, de la Cruz M, Büsing M. Short-term results of transit bipartition to promote weight loss after laparoscopic sleeve gastrectomy. Ann Surg Open. 2021;2:e102.
90. Ribeiro R, Viveiros O, Taranu V, Rossoni C. One anastomosis transit bipartition (OATB): rational and mid-term outcomes. Obes Surg. 2024;34:371-81.
91. Santoro S, Mota FC, de Aquino CGG, de Godoy EP. Common channel length and implications to the weight loss. Updates Surg. 2025;77:2145-50.
92. Mahdy T, Al Wahedi A, Schou C. Efficacy of single anastomosis sleeve ileal (SASI) bypass for type-2 diabetic morbid obese patients: gastric bipartition, a novel metabolic surgery procedure: a retrospective cohort study. Int J Surg. 2016;34:28-34.
93. Oliveira CR, Santos-Sousa H, Costa MP, et al. Efficiency and safety of single anastomosis sleeve ileal (SASI) bypass in the treatment of obesity and associated comorbidities: a systematic review and meta-analysis. Langenbecks Arch Surg. 2024;409:221.
94. Aghajani E, Schou C, Gislason H, Nergaard BJ. Mid-term outcomes after single anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity. Surg Endosc. 2023;37:6220-7.
95. Tarnowski W, Barski K, Jaworski P, et al. Single anastomosis sleeve ileal bypass (SASI): a single-center initial report. Wideochir Inne Tech Maloinwazyjne. 2022;17:365-71.
96. Attia N, Ben Hadj Khlifa M, Ben Fadhel N. The single anastomosis sleeve ileal (SASI) bypass: a review of the current literature on outcomes and statistical results. Obes Med. 2021;27:100370.
97. Khalaf M, Hamed H. Single-anastomosis sleeve ileal (SASI) bypass: hopes and concerns after a two-year follow-up. Obes Surg. 2021;31:667-74.
98. Salama TMS, Sabry K, Ghamrini YE. Single anastomosis sleeve ileal bypass: new step in the evolution of bariatric surgeries. J Invest Surg. 2017;30:291-6.
99. Dowgiałło-Gornowicz N, Waczyński K, Waczyńska K, Lech P. Single anastomosis sleeve ileal (SASI) bypass as a primary and revisional procedure: a single-centre experience. Wideochir Inne Tech Maloinwazyjne. 2023;18:510-5.
100. Hosseini SV, Moeinvaziri N, Medhati P, et al. Optimal length of biliopancreatic limb in single anastomosis sleeve gastrointestinal bypass for treatment of severe obesity: efficacy and concerns. Obes Surg. 2022;32:2582-90.
101. Sewefy AM, Atyia AM, Mohammed MM, Kayed TH, Hamza HM. Single anastomosis sleeve jejunal (SAS-J) bypass as a treatment for morbid obesity, technique and review of 1986 cases and 6 years follow-up. Retrospective cohort. Int J Surg. 2022;102:106662.
102. Mahdy T, Gado W, Alwahidi A, Schou C, Emile SH. Sleeve gastrectomy, one-anastomosis gastric bypass (OAGB), and single anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity: a retrospective cohort study. Obes Surg. 2021;31:1579-89.
103. El-mahdy HM, Abd El-monem AA, Saied AEFM, El-dahshan TA. The metabolic outcome of single anastomosis sleeve ileal operation. Al-Azhar Med J. 2020;49:1629-38.
104. Kandel MM, Hassan M, Ali RF. One year follow-up of laparoscopic single anastomosis sleeve ileal bypass in super-morbidly obese patients. Med Update. 2023;14:37-62.
105. Emile SH, Mahdy T, Schou C, Kramer M, Shikora S. Systematic review of the outcome of single-anastomosis sleeve ileal (SASI) bypass in treatment of morbid obesity with proportion meta-analysis of improvement in diabetes mellitus. Int J Surg. 2021;92:106024.
106. Kamal A, El Azawy M, Hassan TAA. Unpredictable malnutrition and short-term outcomes after single anastomosis sleeve ileal (SASI) bypass in obese patients. J Obes. 2023;2023:5582940.
107. Kavlakoglu B, Senol M. IBC-Oxford University2023_BJSPoster_14. Short-term outcomes of single-anastomosis sleeve-ileal bypass (SASI). Br J Surg. 2023;110:znad382.041.
108. Sewefy AM, Abdelzaher MA, Sabry K, et al. Single anastomosis sleeve jejunal (SAS-J) bypass vs single anastomosis sleeve ileal (SASI) bypass, prospective randomized controlled clinical trial. Int J Surg. 2025;111:5268-79.
